Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOREISAN-HF Trial
jRCTs051200101Active, not recruiting
- Sponsor
- Tsumura & Co.
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of oreongsan in chronic heart failure (CHF) (2 arms), sponsored by Tsumura & Co. Primary endpoint: Improvement of cardiac edema. Started Jan 2021; status: active, not recruiting.
02
Drugs
oreongsan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on jRCTs051200101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051200101.